Zipp, F <br/><br/>
Blockade of chemokine signaling in patients with multiple sclerosis.  [electronic resource] 

 -  Neurology  Nov 2006 
 - 1880-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.wnl.0000244420.68037.86  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Central Nervous System--drug effects<br/>Chemokines--antagonists & inhibitors<br/>Chemotaxis, Leukocyte--drug effects<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Magnetic Resonance Imaging<br/>Multiple Sclerosis--drug therapy<br/>Phenylurea Compounds--administration & dosage<br/>Piperidines--administration & dosage<br/>Placebos<br/>Receptors, CCR1<br/>Receptors, Chemokine--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Treatment Outcome